BeiGene announced that the US FDA has accepted a supplemental new drug application or BRUKINSA® for the treatment of adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
[BeiGene]
Sorry, but the selected Zotpress account can't be found.
